Blog
RSS FeedPosted by Michael Wonder on 03 Oct 2025
Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride) in the UK at a list price equal to the US launch price
22 September 2025 - Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride), in the UK in 2026. ...
Posted by Michael Wonder on 04 Aug 2017
How much should we spend on health care?
3 August 2017 - What’s the right amount of spending on health care? And how does the UK’s spending compare ...
Posted by Michael Wonder on 16 Sep 2015
NICE proposes further research for Dupuytren’s contracture treatment
16 September 2015 - NICE has today confirmed its previous final draft guidance not to recommend collagenase clostridium histolyticum (Xiapex, Swedish ...
Posted by Michael Wonder on 26 Aug 2015
NICE green light for Sankyo's bloodthinner Lixiana
25 August 2015 - The National Institute for Health and Care Excellence has issued a final recommendation for Sankyo’s blood thinner ...
Posted by Michael Wonder on 26 Aug 2015
Final NICE green light for Takeda's Entyvio
26 August 2015 - Crohn’s disease patients can now get routine access to treatment with Takeda’s biologic Entyvio on the National ...